<DOC>
	<DOC>NCT00337831</DOC>
	<brief_summary>Patients will be treated with hemodiafiltration (HDF) in postdilution mode, as a control therapy, during 9 weeks. During week 5 the 1st intervention treatment, predilution hemofiltration (HF) or predilution HDF, will be performed as a midweek session. After 4 additional weeks of control therapy the other intervention treatment will be performed. Samples will be taken during week 4, 5 and 9: from inlet blood flow (0, 30, 60, 120 and 240 min), from outlet blood flow and dialysate outflow (30, 60, 120 and 240 min).</brief_summary>
	<brief_title>Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<criteria>stable on hemodialysis &gt;= 6 months of which presently on highflux HD &gt;= 1 month 18 years &lt; age &lt; 85 years blood flow rate &gt;= 300ml/min expected survival &lt; 1 year expected transplant within &lt; 1 year infectious diseases pregnancy chronic inflammation condition treated with single needle dialysis presently treated with hemodiafiltration or lowflux hemodiafiltration expected intradialytic body weight gain &gt;= 4kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>